Ronald J. Ellis Jr. is Chief Strategy Officer at Pacira BioSciences, Inc. (PCRX). They have made 1 open-market trade across 1 company since 2023, most recently 2023-06-07.
CIK 0001790670
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PCRX | 32,071 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2023-06-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCRX | SELL | 2023-06-06 | 2023-06-07 | $38.42 | $87K | +9.4% | +1.4% | -7.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.